These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

8975 related items for PubMed ID: 2142142

  • 1. Bimodal relationship between invasion of the amniotic membrane and plasminogen activator activity.
    Tsuboi R, Rifkin DB.
    Int J Cancer; 1990 Jul 15; 46(1):56-60. PubMed ID: 2142142
    [Abstract] [Full Text] [Related]

  • 2. Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.
    Meissauer A, Kramer MD, Schirrmacher V, Brunner G.
    Exp Cell Res; 1992 Apr 15; 199(2):179-90. PubMed ID: 1531956
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells.
    Festuccia C, Dolo V, Guerra F, Violini S, Muzi P, Pavan A, Bologna M.
    Clin Exp Metastasis; 1998 Aug 15; 16(6):513-28. PubMed ID: 9872599
    [Abstract] [Full Text] [Related]

  • 4. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade.
    Baricos WH, Cortez SL, el-Dahr SS, Schnaper HW.
    Kidney Int; 1995 Apr 15; 47(4):1039-47. PubMed ID: 7540230
    [Abstract] [Full Text] [Related]

  • 5. Urokinase-type and tissue-type plasminogen activators are essential for in vitro invasion of human melanoma cells.
    Meissauer A, Kramer MD, Hofmann M, Erkell LJ, Jacob E, Schirrmacher V, Brunner G.
    Exp Cell Res; 1991 Feb 15; 192(2):453-9. PubMed ID: 1899072
    [Abstract] [Full Text] [Related]

  • 6. Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator.
    Tiberio A, Farina AR, Tacconelli A, Cappabianca L, Gulino A, Mackay AR.
    Int J Cancer; 1997 Nov 27; 73(5):740-8. PubMed ID: 9398056
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of B16BL6 melanoma invasion by tyrosine and phenylalanine deprivation is associated with decreased secretion of plasminogen activators and increased plasminogen activator inhibitors.
    Pelayo BA, Fu YM, Meadows GG.
    Clin Exp Metastasis; 1999 Nov 27; 17(10):841-8. PubMed ID: 11089882
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor.
    Mori T, Abe T, Wakabayashi Y, Hikawa T, Matsuo K, Yamada Y, Kuwano M, Hori S.
    J Neurooncol; 2000 Nov 27; 46(2):115-23. PubMed ID: 10894364
    [Abstract] [Full Text] [Related]

  • 9. Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion.
    Bizik J, Lizonová A, Stephens RW, Grófová M, Vaheri A.
    Cell Regul; 1990 Nov 27; 1(12):895-905. PubMed ID: 1712633
    [Abstract] [Full Text] [Related]

  • 10. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 27; 48(8):623-32. PubMed ID: 8808830
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X, Chaudhry A, Chintala SK.
    Mol Vis; 2003 Jun 12; 9():238-48. PubMed ID: 12813409
    [Abstract] [Full Text] [Related]

  • 12. Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor alphaVbeta3.
    Khatib AM, Nip J, Fallavollita L, Lehmann M, Jensen G, Brodt P.
    Int J Cancer; 2001 Feb 01; 91(3):300-8. PubMed ID: 11169951
    [Abstract] [Full Text] [Related]

  • 13. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma.
    Wakita T, Hayashi T, Nishioka J, Tamaru H, Akita N, Asanuma K, Kamada H, Gabazza EC, Ido M, Kawamura J, Suzuki K.
    Int J Cancer; 2004 Feb 10; 108(4):516-23. PubMed ID: 14696115
    [Abstract] [Full Text] [Related]

  • 14. Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.
    Levenson AS, Kwaan HC, Svoboda KM, Weiss IM, Sakurai S, Jordan VC.
    Br J Cancer; 1998 Jul 10; 78(1):88-95. PubMed ID: 9662256
    [Abstract] [Full Text] [Related]

  • 15. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells.
    Lim YT, Sugiura Y, Laug WE, Sun B, Garcia A, DeClerck YA.
    J Cell Physiol; 1996 May 10; 167(2):333-40. PubMed ID: 8613475
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system.
    Ramont L, Pasco S, Hornebeck W, Maquart FX, Monboisse JC.
    Exp Cell Res; 2003 Nov 15; 291(1):1-10. PubMed ID: 14597403
    [Abstract] [Full Text] [Related]

  • 17. Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells.
    Abe T, Mori T, Kohno K, Seiki M, Hayakawa T, Welgus HG, Hori S, Kuwano M.
    Clin Exp Metastasis; 1994 Jul 15; 12(4):296-304. PubMed ID: 8039304
    [Abstract] [Full Text] [Related]

  • 18. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade.
    Le DM, Besson A, Fogg DK, Choi KS, Waisman DM, Goodyer CG, Rewcastle B, Yong VW.
    J Neurosci; 2003 May 15; 23(10):4034-43. PubMed ID: 12764090
    [Abstract] [Full Text] [Related]

  • 19. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.
    Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P.
    EMBO J; 1997 May 01; 16(9):2319-32. PubMed ID: 9171346
    [Abstract] [Full Text] [Related]

  • 20. Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells.
    Liu G, Shuman MA, Cohen RL.
    Int J Cancer; 1995 Feb 08; 60(4):501-6. PubMed ID: 7829264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 449.